CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Core Laboratories Inc. /DE/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$10.15+0.15 (+1.50%)
Close on Oct 19, 2026
- Market cap
- $475.81M
- P/E (TTM)
- 19.5
- Dividend yield
- 0.39%
Margins
Share of revenue, fiscal years 2020 to 2025
Gross margin
20.7%
Operating margin
10.7%
Net margin
5.6%
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +0.5% | +2.4% | – | – | |
| Gross profit | +5.4% | +4.3% | – | – | |
| Operating income | -3.6% | +10.8% | – | – | |
| Net income | -5.5% | +15.1% | – | – | |
| EPS, diluted | -4.5% | +14.5% | – | – | |
| Free cash flow | -42.0% | +20.5% | – | – | |
| Dividend per share | 0.0% | 0.0% | – | – |
Returns and balance sheet
6 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2020 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | 11.6% | |
| Return on assets | – | – | 5.1% | |
| Current ratio | – | – | 2.02 | |
| Debt to equity | – | – | 0.41 | |
| Net debt to EBITDA | – | – | 1.23× | |
| Interest coverage | – | – | 5.3× | |
| Inventory turnover | – | – | 7.3× | |
| Capex to revenue | – | – | 2.1% | |
| Diluted shares | – | – | 47M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Core Laboratories generated $179.74M from operations and spent $98.82M on capital expenditure, dividends and share buybacks. 58% of that went back into the business.
Generated
$179.74M
Used
$98.82M
Capital expenditure$57.43M58%Dividends$9.30M9%Share buybacks$32.09M32%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin5.6%
×Asset turnover0.90×
×Equity multiplier2.28×
=Return on equity, FY202511.6%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 5.6% | 0.90× | 2.28× | 11.6% |
| FY2024 | 6.0% | 0.89× | 2.49× | 13.3% |
| FY2023 | 7.2% | 0.88× | 2.85× | 17.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
7of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$29.67M
- Cash generatingOperating cash flow above zero$37.03M
- Return on assets improvedROA up on the prior year5.4% → 5.1%
- Earnings backed by cashOperating cash flow above net income$37.03M vs $29.67M
- Less leverageLong-term debt to assets fell21.6% → 18.9%
- Better liquidityCurrent ratio rose2.16 → 2.02
- No dilutionShare count did not rise48M → 47M
- Gross margin improvedGross margin up on the prior year19.72% → 20.69%
- More efficientAsset turnover rose0.89 → 0.90